1. Home
  2. HTFL

as of 03-23-2026 2:48pm EST

$26.94
+$1.06
+4.10%
Stocks Nasdaq

HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.

Founded: 2007 Country:
United States
United States
Employees: N/A City: MOUNTAIN VIEW
Market Cap: 2.2B IPO Year: N/A
Target Price: $38.20 AVG Volume (30 days): 1.3M
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $20.13 - $41.22 Next Earning Date: 03-18-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 23.36% Revenue Growth (next year): 23.03%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Latest Heartflow Inc. News

HTFL Breaking Stock News: Dive into HTFL Ticker-Specific Updates for Smart Investing

All HTFL News

Share on Social Networks: